NIPH Clinical Trials Search

Basic Information

Recruitment status
Health condition(s) or Problem(s) studied	Advanced or metastatic or recurrent non-small cell lung cancer
Date of first enrollment	09/09/2005
Target sample size
Countries of recruitment
Study type	Interventional
Intervention(s)	investigational material(s) Generic name etc : erlotinib hydrochloride INN of investigational material : Therapeutic category code : 429 Other antitumor agents Dosage and Administration for Investigational material : Oral

Outcome(s)

Primary Outcome	Efficacy and safety
Secondary Outcome

Key inclusion & exclusion criteria

Age minimum	Not applicable
Age maximum	Not applicable
Gender
Include criteria	patients with advanced/metastatic or recurrent NSCLC (stage IIIB or IV) who have failed at least one previous platinum chemotherapy regimen.
Exclude criteria